Is leishmaniasis endemic in this location?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Leishmaniasis Endemicity Assessment

Direct Answer Based on Location

The endemicity of leishmaniasis depends entirely on the specific geographic location in question, but I can provide definitive guidance based on established endemic regions worldwide.

Global Endemic Regions

New World (Americas)

High-Risk Endemic Areas:

  • South of the Amazon basin in Bolivia, Peru, and Brazil (the "mucosal belt") represents the highest risk area for mucosal leishmaniasis 1
  • Moderate-risk areas extend from south of Nicaragua to the Amazon basin 1
  • Low-risk areas include New World endemic regions north of Costa Rica 1

United States Endemic Status:

  • Leishmaniasis is definitively endemic in the United States, particularly in Texas and Oklahoma, with 59% of 69 identified cases (2007-2017) occurring in patients with no travel history outside the US within 10 years 2
  • Leishmania mexicana was identified in 100% of speciated endemic US cases 2
  • The median age at diagnosis for endemic US cases was 61 years, with 68% occurring in females 2

Old World (Africa, Middle East, Asia)

Major Endemic Regions:

  • Asia and Africa are most endemic for visceral leishmaniasis, commonly affecting young children 3
  • Mediterranean destinations are emerging as main areas of acquisition for European travelers 4
  • Sri Lanka has seen rising incidence since 2008, with 90% of cases concentrated in Anuradhapura, Hambantota, Polonnaruwa, Kurunegala, and Matara districts 5

Clinical Implications by Geographic Risk

For Exposures in High-Risk Mucosal Belt (Bolivia, Peru, Brazil south of Amazon)

Treatment is mandatory even for healed lesions because the risk of developing destructive mucosal leishmaniasis is substantial with Viannia species, particularly L. (V.) braziliensis 1

For Exposures North of Costa Rica or Old World

Observation may be reasonable for simple cutaneous leishmaniasis (single small lesion <1 cm, non-cosmetically important location, immunocompetent host, spontaneously healing) because mucosal leishmaniasis risk is low 1

For US-Acquired Cases

Consider endemic acquisition in patients from Texas, Oklahoma, or other southern states even without travel history, as L. mexicana is established in these regions 2

Seasonal and Environmental Factors

Peak transmission periods vary by region:

  • North-central Sri Lanka: July to September 5
  • Southern Sri Lanka: October to December 5
  • Maximum temperature, humidity, and wind speed significantly correlate with transmission in endemic regions 5

Diagnostic Approach for Endemic vs. Travel-Associated Cases

Species identification is critical because it determines treatment strategy and prognosis 1:

  • Viannia species from Costa Rica southward require systemic treatment regardless of lesion appearance 1
  • Old World species or New World non-Viannia species may be observed if lesions are simple and healing 1

Common Pitfalls

Do not assume leishmaniasis requires international travel - endemic transmission occurs in the southern United States, and climate models predict doubling of exposed US citizens by 2080 2

Do not rely solely on recent travel history - leishmaniasis can manifest months to years after exposure, particularly for mucosal disease 1, 4

Do not dismiss the diagnosis in immunocompromised patients from endemic areas - reactivation of dormant infection can occur with HIV, transplantation, or immunosuppressive medications 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Visceral leishmaniasis: a forgotten epidemic.

Archives of disease in childhood, 2016

Research

Leishmaniasis, an emerging infection in travelers.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.